Connecticut's House Bill 6771, introduced on March 18, 2025, aims to enhance patient access to necessary medical treatments by streamlining prior authorization processes and expanding coverage for biomarker testing. This legislation addresses significant concerns regarding delays in treatment and the complexities surrounding insurance approvals, which can hinder timely medical care for patients.

One of the bill's key provisions mandates that health insurance entities must respond to prior authorization requests within specified timeframes—seven days for non-urgent requests and 72 hours for urgent ones. This change is expected to alleviate the frustrations many patients face when waiting for approval before receiving critical medical services. Additionally, the bill requires these entities to publicly post their prior authorization processes online, promoting transparency and accountability.

Another notable aspect of House Bill 6771 is its focus on biomarker testing, which plays a crucial role in personalized medicine. The bill defines biomarker testing and establishes guidelines for its coverage, ensuring that patients have access to tests that can inform treatment decisions. This is particularly significant for conditions like cancer, where biomarker tests can guide targeted therapies.

The introduction of this bill has sparked discussions among lawmakers, healthcare providers, and insurance companies. Proponents argue that it will lead to better health outcomes and reduce unnecessary delays in care. However, some insurance representatives have expressed concerns about the potential increase in costs associated with expanded coverage and the administrative burden of adhering to the new timelines.

The implications of House Bill 6771 extend beyond immediate healthcare access. By facilitating quicker treatment decisions and promoting the use of biomarker testing, the bill could lead to improved patient outcomes and potentially lower long-term healthcare costs. As the bill progresses through the legislative process, its supporters are optimistic about its potential to reshape the landscape of patient care in Connecticut.

As the effective date of January 1, 2026, approaches, stakeholders will be closely monitoring the bill's developments, anticipating its impact on both the healthcare system and the lives of Connecticut residents.